Pular para o conteúdo
Encefalopatia epiléptica de início precoce inespecífica
ORPHA:442835CID-10 · G40.4DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
neuroInício neonatalHerança AD/AR/Unknown/XL
Também conhecida comoEOEE
Sinônimos clínicos: Encefalopatia epilética de causa indeterminada e início precoce

Síndrome epiléptica infantil rara, caracterizada pelo início precoce de convulsões de tipo e gravidade variáveis, potencialmente associadas a um espectro de sinais e sintomas clínicos, incluindo atraso ou falta de desenvolvimento psicomotor, deficiência intelectual, desenvolvimento deficiente ou ausente da fala, anormalidades comportamentais, hipotonia, distúrbios motores, espasticidade, microcefalia e características faciais dismórficas, entre outros. Os achados de imagem cerebral também são variáveis ​​e podem incluir atrofia cerebral ou anomalias da substância branca.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A encefalopatia epiléptica de início precoce inespecífica é uma condição rara que começa logo nos primeiros meses de vida, causando crises epilépticas frequentes e de diferentes tipos. A família costuma perceber que a criança tem atraso para se desenvolver, dificuldades na fala, rigidez ou fraqueza nos músculos e problemas para engolir. A causa costuma envolver alterações em genes importantes para o cérebro, como TRAK1, SCN8A e WWOX. No Brasil, o SUS não possui um protocolo exclusivo para esta síndrome, mas dispensa medicamentos anticonvulsivantes pelo protocolo geral de epilepsia e oferece atendimento de reabilitação.

📋
Informacoes curadas por IA — podem conter imprecisoes

Síndrome epiléptica infantil rara, caracterizada pelo início precoce de convulsões de tipo e gravidade variáveis, potencialmente associadas a um espectro de sinais e sintomas clínicos, incluindo atraso ou falta de desenvolvimento psicomotor, deficiência intelectual, desenvolvimento deficiente ou ausente da fala, anormalidades comportamentais, hipotonia, distúrbios motores, espasticidade, microcefalia e características faciais dismórficas, entre outros. Os achados de imagem cerebral também são variáveis ​​e podem incluir atrofia cerebral ou anomalias da substância branca.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
2 procedimentos SIGTAPCID-10: G40.4
🇧🇷Dados SUS / DATASUS
EXAMES E PROCEDIMENTOS RELACIONADOS (2)
•
Sequenciamento completo do exoma (WES)
•
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
64 sintomas
👁️
Olhos
10 sintomas
😀
Face
7 sintomas
🫃
Digestivo
4 sintomas
📏
Crescimento
4 sintomas
💪
Músculos
4 sintomas

+ 57 sintomas em outras categorias

Características mais comuns

90%prev.
Encefalopatia
Muito frequente (99-80%)
55%prev.
Deficiência intelectual
Frequente (79-30%)
55%prev.
Hiporreflexia
Frequente (79-30%)
55%prev.
Atraso no desenvolvimento da fala e da linguagem
Frequente (79-30%)
55%prev.
EEG com atividade lenta multifocal
Frequente (79-30%)
55%prev.
Atraso global do desenvolvimento
Frequente (79-30%)
159sintomas
Muito frequente (1)
Frequente (10)
Ocasional (31)
Muito raro (6)
Sem dados (111)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 159 características clínicas mais associadas, ordenadas por frequência.

EncefalopatiaEncephalopathy
Muito frequente (99-80%)90%
Deficiência intelectualIntellectual disability
Frequente (79-30%)55%
HiporreflexiaHyporeflexia
Frequente (79-30%)55%
Atraso no desenvolvimento da fala e da linguagemDelayed speech and language development
Frequente (79-30%)55%
EEG com atividade lenta multifocalEEG with multifocal slow activity
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa2desde 2024
Últimos 10 anos8publicações
Pico20163 papers
Linha do tempo
2024Hoje · 2026📈 2016Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

55 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, Not applicable, X-linked recessive.

Curadoria gene-doença

fontes oficiais
CACNA1A AARS1YWHAG
TRAK1Trafficking kinesin-binding protein 1Disease-causing germline mutation(s) (loss of function) inAltamente restrito
VIAS BIOLÓGICAS (2)
RHOT2 GTPase cycleRHOT1 GTPase cycle
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 68

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE68 is an autosomal recessive form characterized by onset of twitching and/or myoclonic jerks in infancy. The disorder progresses to refractory generalized tonic-clonic seizures, often resulting in status epilepticus, loss of developmental milestones, and early death. Other features include delayed development, axial hypotonia, spasticity of the limbs, and clonus.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
36.8 TPM
Cerebelo
36.1 TPM
Tireoide
33.8 TPM
Skin Not Sun Exposed Suprapubic
31.4 TPM
Glândula salivar
30.6 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 68undetermined early-onset epileptic encephalopathy
HGNC:29947UniProt:Q9UPV9
WWOXWW domain-containing oxidoreductaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Nuclear signaling by ERBB4Activation of the TFAP2 (AP-2) family of transcription factorsNegative regulation of activity of TFAP2 (AP-2) family transcription factors
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
13.8 TPM
Cérebro - Hemisfério cerebelar
12.1 TPM
Cerebelo
11.2 TPM
Brain Spinal cord cervical c-1
10.5 TPM
Nervo tibial
8.2 TPM
OUTRAS DOENÇAS (5)
autosomal recessive spinocerebellar ataxia 12esophageal cancerdevelopmental and epileptic encephalopathy, 28esophageal squamous cell carcinoma
HGNC:12799UniProt:Q9NZC7
GABRB1Gamma-aminobutyric acid receptor subunit beta-1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
GABA receptor activationSignaling by ERBB4
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 45

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Nucleus accumbens basal ganglia
2.9 TPM
Brain Caudate basal ganglia
2.8 TPM
Pituitária
2.3 TPM
Córtex cerebral
2.3 TPM
Brain Frontal Cortex BA9
2.3 TPM
OUTRAS DOENÇAS (1)
developmental and epileptic encephalopathy, 45
HGNC:HGNC:4081UniProt:P18505
FBXO28F-box only protein 28Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 100

A form of epileptic encephalopathy, a heterogeneous group of early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE100 is an autosomal dominant, severe form characterized by global developmental delay and onset of variable types of seizures in the first months or years of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
30.6 TPM
Skin Not Sun Exposed Suprapubic
26.9 TPM
Fibroblastos
21.6 TPM
Cérebro - Hemisfério cerebelar
20.7 TPM
Artéria tibial
20.0 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy 100undetermined early-onset epileptic encephalopathy
HGNC:29046UniProt:Q9NVF7
FOXG1Forkhead box protein G1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
FOXO-mediated transcription of cell cycle genesRegulation of MECP2 expression and activity
MECANISMO DE DOENÇA

Rett syndrome congenital variant

A severe neurodevelopmental disorder with features of classic Rett syndrome but earlier onset in the first months of life. Clinical features include progressive microcephaly, hypotonia, irresponsiveness and irritability in the neonatal period, intellectual disability, psychomotor regression and stereotypical movements.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
29.2 TPM
Córtex cerebral
25.2 TPM
Brain Anterior cingulate cortex BA24
23.0 TPM
Brain Nucleus accumbens basal ganglia
22.4 TPM
Brain Caudate basal ganglia
20.6 TPM
OUTRAS DOENÇAS (3)
FOXG1 disorderundetermined early-onset epileptic encephalopathy14q12 microdeletion syndrome
HGNC:3811UniProt:P55316
KCNC2Voltage-gated potassium channel KCNC2Disease-causing germline mutation(s) (loss of function) inTolerante
VIAS BIOLÓGICAS (2)
Glucagon-like Peptide-1 (GLP1) regulates insulin secretionVoltage gated Potassium channels
EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
37.0 TPM
Brain Anterior cingulate cortex BA24
22.2 TPM
Córtex cerebral
22.1 TPM
Pituitária
9.7 TPM
Hipotálamo
9.1 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy 103undetermined early-onset epileptic encephalopathy
HGNC:6234UniProt:Q96PR1
NUS1Dehydrodolichyl diphosphate synthase complex subunit NUS1Disease-causing germline mutation(s) inDesconhecido
VIAS BIOLÓGICAS (2)
Synthesis of dolichyl-phosphateDefective DHDDS causes RP59
MECANISMO DE DOENÇA

Congenital disorder of glycosylation 1AA

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. CDG1AA inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
39.3 TPM
Fibroblastos
32.7 TPM
Tireoide
21.5 TPM
Artéria tibial
19.6 TPM
Glândula salivar
19.3 TPM
OUTRAS DOENÇAS (3)
intellectual disability, autosomal dominant 55, with seizurescongenital disorder of glycosylation, type IAAundetermined early-onset epileptic encephalopathy
HGNC:21042UniProt:Q96E22
SCN8ASodium channel protein type 8 subunit alphaDisease-causing germline mutation(s) (gain of function) inAltamente restrito
VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Cognitive impairment with or without cerebellar ataxia

A disorder characterized by markedly delayed cognitive and motor development, attention deficit disorder, and cerebellar ataxia. Features include bilateral esophoria, strabismatic amblyopia, unsustained gaze evoked nystagmus on horizontal gaze, ataxic gait, dysmetria in the upper limbs and dysarthria, with normal strength, tone, and reflexes.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
28.2 TPM
Cérebro - Hemisfério cerebelar
26.4 TPM
Brain Frontal Cortex BA9
17.9 TPM
Córtex cerebral
14.8 TPM
Pituitária
10.9 TPM
OUTRAS DOENÇAS (9)
seizures, benign familial infantile, 5developmental and epileptic encephalopathy, 13myoclonus, familial, 2cognitive impairment with or without cerebellar ataxia
HGNC:10596UniProt:Q9UQD0
SLC38A3Sodium-coupled neutral amino acid transporter 3Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Amino acid transport across the plasma membrane
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 102

A form of epileptic encephalopathy, a heterogeneous group of early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE102 is an autosomal recessive form characterized by onset of variable types of seizures in infancy.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
160.7 TPM
Brain Spinal cord cervical c-1
26.5 TPM
Pâncreas
21.8 TPM
Córtex cerebral
19.5 TPM
Brain Caudate basal ganglia
17.3 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy 102undetermined early-onset epileptic encephalopathy
HGNC:18044UniProt:Q99624
CYFIP2Cytoplasmic FMR1-interacting protein 2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
FCGR3A-mediated phagocytosisRHO GTPases Activate WASPs and WAVEsRegulation of actin dynamics for phagocytic cup formationVEGFA-VEGFR2 PathwayRAC1 GTPase cycle
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 65

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE65 is an autosomal dominant form characterized by onset of intractable seizures usually in the first 6 months of life and severe to profound psychomotor developmental delay.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
140.8 TPM
Cerebelo
122.9 TPM
Brain Frontal Cortex BA9
98.0 TPM
Linfócitos
94.4 TPM
Córtex cerebral
88.7 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 65undetermined early-onset epileptic encephalopathy
HGNC:13760UniProt:Q96F07
ATP1A2Sodium/potassium-transporting ATPase subunit alpha-2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Ion homeostasisIon transport by P-type ATPasesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Migraine, familial hemiplegic, 2

A subtype of migraine with aura associated with hemiparesis in some families. Migraine is a disabling symptom complex of periodic headaches, usually temporal and unilateral. Headaches are often accompanied by irritability, nausea, vomiting and photophobia, preceded by constriction of the cranial arteries. Migraine with aura is characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred vision, hallucinations, vertigo, numbness and difficulty in concentrating and speaking.

OUTRAS DOENÇAS (7)
migraine, familial hemiplegic, 2fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic faciesdevelopmental and epileptic encephalopathy 98alternating hemiplegia of childhood 1
HGNC:800UniProt:P50993
SLC13A5Na(+)/citrate cotransporterDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
SLC-mediated transport of organic anions
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta

An autosomal recessive disease characterized by subclinical seizures appearing in the first days of life, evolving to severe epileptic disease. Affected individuals have profound or severe delayed development with lack of speech, and most patients do not acquire the ability to sit. Additional variable features include axial hypotonia, peripheral hypertonia, and abnormal involuntary movements such as dystonia and choreoathetosis. Dental abnormalities, including delayed eruption, hypodontia, tooth hypoplasia, yellow discoloration, thin enamel, and enamel chipping are observed in most patients.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
261.8 TPM
Brain Nucleus accumbens basal ganglia
7.1 TPM
Córtex cerebral
7.0 TPM
Brain Anterior cingulate cortex BA24
6.0 TPM
Brain Frontal Cortex BA9
5.2 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (3)
developmental and epileptic encephalopathy, 25undetermined early-onset epileptic encephalopathyamelocerebrohypohidrotic syndrome
HGNC:23089UniProt:Q86YT5
ACTL6BActin-like protein 6BDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not knownRMTs methylate histone argininesFormation of neuronal progenitor and neuronal BAF (npBAF and nBAF)
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 76

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE76 is an autosomal recessive form that may result in death in childhood.

OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy, 76intellectual developmental disorder with severe speech and ambulation defectscomplex neurodevelopmental disorderundetermined early-onset epileptic encephalopathy
HGNC:160UniProt:O94805
DHDDSDehydrodolichyl diphosphate synthase complex subunit DHDDSDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Synthesis of dolichyl-phosphate
MECANISMO DE DOENÇA

Retinitis pigmentosa 59

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
95.1 TPM
Cérebro - Hemisfério cerebelar
91.4 TPM
Tecido adiposo
33.3 TPM
Fibroblastos
27.0 TPM
Skin Sun Exposed Lower leg
25.7 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 59developmental delay and seizures with or without movement abnormalitiesretinitis pigmentosaundetermined early-onset epileptic encephalopathy
HGNC:20603UniProt:Q86SQ9
ATP6V1AV-type proton ATPase catalytic subunit ADisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (6)
Insulin receptor recyclingTransferrin endocytosis and recyclingIon channel transportROS and RNS production in phagocytesAmino acids regulate mTORC1
MECANISMO DE DOENÇA

Cutis laxa, autosomal recessive, 2D

A form of cutis laxa, a disorder characterized by an excessive congenital skin wrinkling, a large fontanelle with delayed closure, a typical facial appearance with downslanting palpebral fissures, and a general connective tissue weakness. Most ARCL2D patients exhibit severe hypotonia as well as cardiovascular and neurologic involvement.

OUTRAS DOENÇAS (4)
autosomal recessive cutis laxa type 2Ddevelopmental and epileptic encephalopathy 93undetermined early-onset epileptic encephalopathyautosomal recessive cutis laxa type 2, classic type
HGNC:851UniProt:P38606
AP3B2AP-3 complex subunit beta-2Disease-causing germline mutation(s) inRestrito
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 48

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE48 is an autosomal recessive form characterized by onset of seizures in the first year of life. Affected individuals manifest global developmental delay, intellectual disability, absent speech, and poor, if any, motor development.

OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 48undetermined early-onset epileptic encephalopathy
HGNC:567UniProt:Q13367
KCNB1Potassium voltage-gated channel subfamily B member 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Glucagon-like Peptide-1 (GLP1) regulates insulin secretionVoltage gated Potassium channels
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 26

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE26 patients manifest multiple types of seizures, delayed psychomotor development, poor or absent speech, hypotonia, hypsarrhythmia.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
21.0 TPM
Córtex cerebral
16.8 TPM
Esôfago - Muscular
13.9 TPM
Esôfago - Junção
10.7 TPM
Brain Anterior cingulate cortex BA24
8.4 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 26undetermined early-onset epileptic encephalopathy
HGNC:6231UniProt:Q14721
CNKSR2Connector enhancer of kinase suppressor of ras 2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (7)
Paradoxical activation of RAF signaling by kinase inactive BRAFSignaling by moderate kinase activity BRAF mutantsSignaling by high-kinase activity BRAF mutantsSignaling downstream of RAS mutantsMAP2K and MAPK activation
MECANISMO DE DOENÇA

Intellectual developmental disorder, X-linked, syndromic, Houge type

A disorder characterized by delayed development, intellectual disability, speech and language delay, and early-onset seizures. Carrier females may be mildly affected.

OUTRAS DOENÇAS (3)
intellectual disability, X-linked, syndromic, Houge typenon-syndromic X-linked intellectual disabilityundetermined early-onset epileptic encephalopathy
HGNC:19701UniProt:Q8WXI2
SYNJ1Synaptojanin-1Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (4)
Synthesis of PIPs at the plasma membraneClathrin-mediated endocytosisSynthesis of IP3 and IP4 in the cytosolSynthesis of IP2, IP, and Ins in the cytosol
MECANISMO DE DOENÇA

Parkinson disease 20, early-onset

An early-onset form of Parkinson disease, a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. PARK20 is characterized by young adult-onset of parkinsonism. Additional features may include seizures, cognitive decline, abnormal eye movements, and dystonia.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
38.4 TPM
Brain Frontal Cortex BA9
35.2 TPM
Cerebelo
33.2 TPM
Córtex cerebral
21.4 TPM
Testículo
18.7 TPM
OUTRAS DOENÇAS (5)
early-onset Parkinson disease 20developmental and epileptic encephalopathy, 53atypical juvenile parkinsonismundetermined early-onset epileptic encephalopathy
HGNC:11503UniProt:O43426
FGF12Fibroblast growth factor 12Disease-causing germline mutation(s) (gain of function) inTolerante
VIAS BIOLÓGICAS (1)
Phase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 47

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
32.8 TPM
Coração - Átrio
25.4 TPM
Glândula adrenal
22.4 TPM
Córtex cerebral
19.0 TPM
Cérebro - Hemisfério cerebelar
18.9 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 47undetermined early-onset epileptic encephalopathy
HGNC:3668UniProt:P61328
UBA5Ubiquitin-like modifier-activating enzyme 5Disease-causing germline mutation(s) (loss of function) inTolerante
VIAS BIOLÓGICAS (2)
Antigen processing: Ubiquitination & Proteasome degradationDengue Virus Attachment and Entry
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 44

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE44 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
53.3 TPM
Linfócitos
40.4 TPM
Tireoide
37.8 TPM
Glândula adrenal
36.8 TPM
Próstata
36.3 TPM
OUTRAS DOENÇAS (3)
spinocerebellar ataxia, autosomal recessive 24developmental and epileptic encephalopathy, 44undetermined early-onset epileptic encephalopathy
HGNC:23230UniProt:Q9GZZ9
DALRD3DALR anticodon-binding domain-containing protein 3Disease-causing germline mutation(s) (loss of function) inTolerante
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 86

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE86 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
125.7 TPM
Tireoide
59.0 TPM
Cervix Endocervix
45.9 TPM
Pituitária
43.5 TPM
Ovário
43.3 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 86undetermined early-onset epileptic encephalopathy
HGNC:25536UniProt:Q5D0E6
SCN3ASodium channel protein type 3 subunit alphaDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisationSensory perception of sweet, bitter, and umami (glutamate) taste
MECANISMO DE DOENÇA

Epilepsy, familial focal, with variable foci 4

An autosomal dominant form of epilepsy characterized by focal seizures arising from different cortical regions, including the temporal, frontal, parietal, and occipital lobes. Seizure types commonly include temporal lobe epilepsy, frontal lobe epilepsy, and nocturnal frontal lobe epilepsy. Some patients may have intellectual disability or autism spectrum disorders. Seizure onset usually occurs in the first or second decades, although later onset has been reported, and there is phenotypic variability within families. A subset of patients have structural brain abnormalities. Penetrance of the disorder is incomplete. FFEVF4 is characterized by onset of focal seizures in the first years of life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
13.0 TPM
Cerebelo
11.3 TPM
Hipotálamo
9.3 TPM
Brain Nucleus accumbens basal ganglia
8.5 TPM
Pituitária
8.1 TPM
OUTRAS DOENÇAS (5)
epilepsy, familial focal, with variable foci 4developmental and epileptic encephalopathy, 62genetic developmental and epileptic encephalopathyfamilial focal epilepsy with variable foci
HGNC:10590UniProt:Q9NY46
PACS2Phosphofurin acidic cluster sorting protein 2Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 66

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE66 is an autosomal dominant form characterized by onset of seizures in first days or weeks of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
188.4 TPM
Cerebelo
113.5 TPM
Cérebro - Hemisfério cerebelar
101.9 TPM
Nervo tibial
89.5 TPM
Substância negra
70.5 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 66undetermined early-onset epileptic encephalopathy
HGNC:23794UniProt:Q86VP3
NECAP1Adaptin ear-binding coat-associated protein 1Disease-causing germline mutation(s) (loss of function) inRestrito
VIAS BIOLÓGICAS (2)
Clathrin-mediated endocytosisCargo recognition for clathrin-mediated endocytosis
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 21

A severe disease characterized by intractable seizures, profound global developmental delay, and persistent severe axial hypotonia as well as appendicular hypertonia.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
130.3 TPM
Cerebelo
92.7 TPM
Brain Frontal Cortex BA9
78.6 TPM
Pituitária
56.8 TPM
Hipotálamo
53.1 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 21undetermined early-onset epileptic encephalopathy
HGNC:24539UniProt:Q8NC96
GABRB2Gamma-aminobutyric acid receptor subunit beta-2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
GABA receptor activationSignaling by ERBB4
MECANISMO DE DOENÇA

Epileptic encephalopathy, infantile or early childhood, 2

A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. IECEE2 is an autosomal dominant condition with variable age at seizure onset, ranging from early infancy to 6 years.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
74.3 TPM
Cerebelo
51.2 TPM
Brain Frontal Cortex BA9
39.5 TPM
Córtex cerebral
20.1 TPM
Brain Anterior cingulate cortex BA24
14.9 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy 92undetermined early-onset epileptic encephalopathy
HGNC:4082UniProt:P47870
GRIN2DGlutamate receptor ionotropic, NMDA 2DDisease-causing germline mutation(s) (gain of function) inAltamente restrito
VIAS BIOLÓGICAS (8)
RAF/MAP kinase cascadeRas activation upon Ca2+ influx through NMDA receptorUnblocking of NMDA receptors, glutamate binding and activationLong-term potentiationNegative regulation of NMDA receptor-mediated neuronal transmission
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 46

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fibroblastos
6.8 TPM
Hipotálamo
6.1 TPM
Córtex cerebral
4.2 TPM
Brain Anterior cingulate cortex BA24
4.1 TPM
Brain Frontal Cortex BA9
3.6 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 46undetermined early-onset epileptic encephalopathy
HGNC:4588UniProt:O15399
NTRK2BDNF/NT-3 growth factors receptorDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (4)
NTF4 activates NTRK2 (TRKB) signalingBDNF activates NTRK2 (TRKB) signalingNTF3 activates NTRK2 (TRKB) signalingActivated NTRK2 signals through FYN
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 58

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE58 is an autosomal dominant condition characterized by onset of refractory seizures in the first days or months of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Anterior cingulate cortex BA24
79.5 TPM
Brain Frontal Cortex BA9
75.0 TPM
Córtex cerebral
74.2 TPM
Brain Caudate basal ganglia
73.0 TPM
Cérebro - Amígdala
73.0 TPM
OUTRAS DOENÇAS (5)
developmental and epileptic encephalopathy, 58obesity, hyperphagia, and developmental delaypilomyxoid astrocytomaearly-onset obesity-hyperphagia-severe developmental delay syndrome
HGNC:8032UniProt:Q16620
FZR1Fizzy-related protein homologDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
SCF-beta-TrCP mediated degradation of Emi1Antigen processing: Ubiquitination & Proteasome degradationAPC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphaseCDK-mediated phosphorylation and removal of Cdc6
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 109

A form of epileptic encephalopathy, a heterogeneous group of early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE109 is an autosomal dominant form characterized by the onset of various types of seizures in the first months or years of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
72.5 TPM
Testículo
70.1 TPM
Cérebro - Hemisfério cerebelar
63.4 TPM
Pituitária
57.4 TPM
Tireoide
45.6 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy 109undetermined early-onset epileptic encephalopathy
HGNC:24824UniProt:Q9UM11
HCN1Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1Disease-causing germline mutation(s) (gain of function) inAltamente restrito
VIAS BIOLÓGICAS (1)
HCN channels
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 24

A disease characterized by early-onset seizures, intellectual disability of varying degrees, and behavioral disturbances or autistic features in most individuals.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
9.1 TPM
Cérebro - Hemisfério cerebelar
5.7 TPM
Nervo tibial
5.3 TPM
Córtex cerebral
5.2 TPM
Cerebelo
4.9 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (4)
generalized epilepsy with febrile seizures plus, type 10developmental and epileptic encephalopathy, 24undetermined early-onset epileptic encephalopathygeneralized epilepsy with febrile seizures plus
HGNC:4845UniProt:O60741
GABRA5Gamma-aminobutyric acid receptor subunit alpha-5Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (1)
GABA receptor activation
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 79

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE79 is an autosomal dominant form characterized by onset of refractory seizures in the first months of life. Brain imaging may show hypomyelination, cerebral atrophy and thinning of the corpus callosum.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Nucleus accumbens basal ganglia
91.3 TPM
Brain Anterior cingulate cortex BA24
37.9 TPM
Brain Frontal Cortex BA9
35.2 TPM
Hipocampo
29.4 TPM
Córtex cerebral
26.2 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 79undetermined early-onset epileptic encephalopathy
HGNC:4079UniProt:P31644
GABBR2Gamma-aminobutyric acid type B receptor subunit 2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
G alpha (i) signalling eventsClass C/3 (Metabotropic glutamate/pheromone receptors)GABA B receptor activationActivation of G protein gated Potassium channelsInhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
MECANISMO DE DOENÇA

Neurodevelopmental disorder with poor language and loss of hand skills

An autosomal dominant disorder characterized by psychomotor developmental stagnation or regression. NDPLHS manifest in the first years of life as loss of purposeful hand movements, loss of language, and intellectual disability.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
84.0 TPM
Córtex cerebral
64.2 TPM
Cérebro - Hemisfério cerebelar
62.8 TPM
Cerebelo
62.5 TPM
Brain Anterior cingulate cortex BA24
40.5 TPM
OUTRAS DOENÇAS (5)
neurodevelopmental disorder with poor language and loss of hand skillsdevelopmental and epileptic encephalopathy, 59atypical Rett syndromeundetermined early-onset epileptic encephalopathy
HGNC:4507UniProt:O75899
UFSP2Ufm1-specific protease 2Disease-causing germline mutation(s) (loss of function) inTolerante
MECANISMO DE DOENÇA

Beukes hip dysplasia

A severe progressive degenerative osteoarthritis of the hip joint with underlying dysplasia confined to that region. Affected individuals are of normal stature and have no associated health problems. Inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
58.0 TPM
Artéria tibial
54.0 TPM
Aorta
51.9 TPM
Testículo
49.6 TPM
Útero
43.7 TPM
OUTRAS DOENÇAS (4)
spondyloepimetaphyseal dysplasia, di rocco typehip dysplasia, Beukes typedevelopmental and epileptic encephalopathy 106undetermined early-onset epileptic encephalopathy
HGNC:25640UniProt:Q9NUQ7
SLC1A2Excitatory amino acid transporter 2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
Astrocytic Glutamate-Glutamine Uptake And MetabolismGlutamate Neurotransmitter Release CycleSLC-mediated transport of amino acids
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 41

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE41 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Caudate basal ganglia
460.3 TPM
Brain Putamen basal ganglia
378.3 TPM
Brain Anterior cingulate cortex BA24
377.3 TPM
Brain Nucleus accumbens basal ganglia
373.1 TPM
Córtex cerebral
361.7 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 41undetermined early-onset epileptic encephalopathy
HGNC:10940UniProt:P43004
DNM1Dynamin-1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (7)
Gap junction degradationFormation of annular gap junctionsRetrograde neurotrophin signallingRecycling pathway of L1MHC class II antigen presentation
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 31A

An autosomal dominant epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
373.8 TPM
Cérebro - Hemisfério cerebelar
367.4 TPM
Brain Frontal Cortex BA9
260.3 TPM
Córtex cerebral
254.5 TPM
Brain Anterior cingulate cortex BA24
127.4 TPM
OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy, 31Adevelopmental and epileptic encephalopathy, 31Bundetermined early-onset epileptic encephalopathyLennox-Gastaut syndrome
HGNC:2972UniProt:Q05193
PPP3CAProtein phosphatase 3 catalytic subunit alphaDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
Ca2+ pathwayCLEC7A (Dectin-1) induces NFAT activationFCERI mediated Ca+2 mobilization
MECANISMO DE DOENÇA

Epileptic encephalopathy, infantile or early childhood, 1

A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. IECEE1 is an autosomal dominant condition with onset of seizures between the first weeks and first years of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
183.2 TPM
Brain Frontal Cortex BA9
158.1 TPM
Brain Caudate basal ganglia
155.4 TPM
Brain Nucleus accumbens basal ganglia
140.0 TPM
Brain Putamen basal ganglia
114.3 TPM
OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy 91arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual developmentundetermined early-onset epileptic encephalopathyautosomal dominant non-syndromic intellectual disability
HGNC:9314UniProt:Q08209
ATP1A3Sodium/potassium-transporting ATPase subunit alpha-3Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
Ion homeostasisIon transport by P-type ATPasesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Dystonia 12

An autosomal dominant dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT12 patients develop dystonia and parkinsonism between 15 and 45 years of age. The disease is characterized by an unusually rapid evolution of signs and symptoms. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability.

OUTRAS DOENÇAS (6)
developmental and epileptic encephalopathy 99cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromedystonia 12alternating hemiplegia of childhood 2
HGNC:801UniProt:P13637
GABRA2Gamma-aminobutyric acid receptor subunit alpha-2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
GABA receptor activation
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 78

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE78 is an autosomal dominant form characterized by onset of refractory seizures in the first days or months of life. Clinical features include severe developmental delay, hypotonia, microcephaly, cortical visual impairment and profound intellectual disability. Some patients manifest a less severe phenotype characterized by pharmacoresponsive epilepsy, autism spectrum disorder and moderate intellectual disability.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
11.9 TPM
Brain Nucleus accumbens basal ganglia
10.7 TPM
Brain Caudate basal ganglia
10.7 TPM
Córtex cerebral
10.6 TPM
Brain Anterior cingulate cortex BA24
10.5 TPM
OUTRAS DOENÇAS (3)
developmental and epileptic encephalopathy, 78undetermined early-onset epileptic encephalopathyalcohol dependence
HGNC:4076UniProt:P47869
CELF2CUGBP Elav-like family member 2Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 97

A form of epileptic encephalopathy, a heterogeneous group of early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE97 is an autosomal dominant form.

OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy 97undetermined early-onset epileptic encephalopathy
HGNC:2550UniProt:O95319
AARS1Alanine--tRNA ligase, cytoplasmicDisease-causing germline mutation(s) (loss of function) inTolerante
VIAS BIOLÓGICAS (1)
Cytosolic tRNA aminoacylation
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, axonal, type 2N

An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.

OUTRAS DOENÇAS (6)
trichothiodystrophy 8, nonphotosensitiveleukoencephalopathy, hereditary diffuse, with spheroids 2developmental and epileptic encephalopathy, 29Charcot-Marie-Tooth disease axonal type 2N
HGNC:20UniProt:P49588
SZT2KICSTOR complex protein SZT2Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (1)
Amino acids regulate mTORC1
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 18

A severe autosomal recessive neurologic disorder characterized by lack of psychomotor development apparent from birth, dysmorphic facial features, early onset of refractory seizures, and thick corpus callosum and persistent cavum septum pellucidum on brain imaging.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
25.3 TPM
Testículo
24.8 TPM
Ovário
22.8 TPM
Pituitária
22.4 TPM
Cerebelo
22.3 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 18undetermined early-onset epileptic encephalopathy
HGNC:29040UniProt:Q5T011
YWHAG14-3-3 protein gammaDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 56

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE56 is an autosomal dominant condition.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
554.5 TPM
Cérebro - Hemisfério cerebelar
317.8 TPM
Brain Anterior cingulate cortex BA24
299.5 TPM
Córtex cerebral
261.1 TPM
Hipotálamo
238.6 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 56undetermined early-onset epileptic encephalopathy
HGNC:12852UniProt:P61981
CACNA1AVoltage-dependent P/Q-type calcium channel subunit alpha-1ADisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Presynaptic depolarization and calcium channel openingRegulation of insulin secretion
MECANISMO DE DOENÇA

Spinocerebellar ataxia 6

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA6 is an autosomal dominant cerebellar ataxia (ADCA), mainly caused by expansion of a CAG repeat in the coding region of CACNA1A. There seems to be a correlation between the repeat number and earlier onset of the disorder.

OUTRAS DOENÇAS (9)
migraine, familial hemiplegic, 1episodic ataxia type 2developmental and epileptic encephalopathy, 42spinocerebellar ataxia type 6
HGNC:1388UniProt:O00555
CACNA1BVoltage-dependent N-type calcium channel subunit alpha-1BDisease-causing germline mutation(s) (loss of function) inAltamente restrito
VIAS BIOLÓGICAS (1)
Presynaptic depolarization and calcium channel opening
MECANISMO DE DOENÇA

Neurodevelopmental disorder with seizures and non-epileptic hyperkinetic movements

An autosomal recessive, complex and progressive neurologic disorder characterized by severe neurodevelopmental delay and developmental regression, epileptic encephalopathy, postnatal microcephaly, hypotonia, and non-epileptic hyperkinetic movement disorder, including myoclonus dystonia, choreoathetosis, or generalized dyskinesia. Disease onset in infancy or first years of life.

OUTRAS DOENÇAS (2)
neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movementsundetermined early-onset epileptic encephalopathy
HGNC:1389UniProt:Q00975
EEF1A2Elongation factor 1-alpha 2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Eukaryotic Translation Elongation
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 33

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
2328.3 TPM
Cérebro - Hemisfério cerebelar
972.3 TPM
Cerebelo
934.2 TPM
Coração - Ventrículo esquerdo
786.7 TPM
Brain Frontal Cortex BA9
785.6 TPM
OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy, 33intellectual disability, autosomal dominant 38undetermined early-onset epileptic encephalopathyautosomal dominant non-syndromic intellectual disability
HGNC:3192UniProt:Q05639
KCNA2Potassium voltage-gated channel subfamily A member 2Disease-causing germline mutation(s) (gain of function) inAltamente restrito
VIAS BIOLÓGICAS (1)
Voltage gated Potassium channels
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 32

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE32 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
35.9 TPM
Cérebro - Hemisfério cerebelar
29.5 TPM
Córtex cerebral
19.8 TPM
Brain Frontal Cortex BA9
18.9 TPM
Nervo tibial
12.2 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 32undetermined early-onset epileptic encephalopathy
HGNC:6220UniProt:P16389
KCNH5Voltage-gated delayed rectifier potassium channel KCNH5Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Voltage gated Potassium channels
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 112

A form of epileptic encephalopathy, a heterogeneous group of early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE112 is an autosomal dominant form characterized by onset in infancy, and a wide range of seizure types including focal and generalized seizures. Cognitive outcomes range from normal intellect to profound intellectual development impairment.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Frontal Cortex BA9
3.3 TPM
Córtex cerebral
2.3 TPM
Hipotálamo
1.1 TPM
Brain Anterior cingulate cortex BA24
0.9 TPM
Pituitária
0.4 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy 112undetermined early-onset epileptic encephalopathy
HGNC:6254UniProt:Q8NCM2
CDK19Cyclin-dependent kinase 19Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
RSV-host interactionsTranscriptional regulation of white adipocyte differentiationPPARA activates gene expression
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 87

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE87 inheritance is autosomal dominant.

OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 87undetermined early-onset epileptic encephalopathy
HGNC:19338UniProt:Q9BWU1
SCN1ASodium channel protein type 1 subunit alphaDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Generalized epilepsy with febrile seizures plus 2

A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
15.1 TPM
Cérebro - Hemisfério cerebelar
10.7 TPM
Cerebelo
9.3 TPM
Córtex cerebral
8.9 TPM
Hipotálamo
6.3 TPM
OUTRAS DOENÇAS (13)
developmental and epileptic encephalopathy, 6Ageneralized epilepsy with febrile seizures plus, type 2developmental and epileptic encephalopathy 6Bfamilial hemiplegic migraine
HGNC:10585UniProt:P35498
SYNGAP1Ras/Rap GTPase-activating protein SynGAPCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
Regulation of RAS by GAPs
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal dominant 5

A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD5 patients show global developmental delay with delayed motor development, hypotonia, moderate-to-severe intellectual disability, and severe language impairment. Epilepsy and autism can be present in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
62.9 TPM
Útero
39.4 TPM
Fallopian Tube
38.5 TPM
Ovário
38.3 TPM
Cervix Endocervix
33.9 TPM
OUTRAS DOENÇAS (3)
intellectual disability, autosomal dominant 5epilepsy with myoclonic atonic seizuresundetermined early-onset epileptic encephalopathy
HGNC:11497UniProt:Q96PV0
GABRG2Gamma-aminobutyric acid receptor subunit gamma-2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
GABA receptor activationSignaling by ERBB4
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 74

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE74 is an autosomal dominant form with onset in the first year of life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
20.3 TPM
Brain Frontal Cortex BA9
19.4 TPM
Cerebelo
15.3 TPM
Córtex cerebral
10.6 TPM
Brain Nucleus accumbens basal ganglia
7.7 TPM
OUTRAS DOENÇAS (7)
febrile seizures, familial, 8developmental and epileptic encephalopathy, 74obsolete Dravet syndromechildhood absence epilepsy
HGNC:4087UniProt:P18507
DEPDC5GATOR1 complex protein DEPDC5Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Amino acids regulate mTORC1
MECANISMO DE DOENÇA

Epilepsy, familial focal, with variable foci 1

An autosomal dominant form of epilepsy characterized by focal seizures arising from different cortical regions in different family members. Many patients have an aura and show automatisms during the seizures, whereas others may have nocturnal seizures. There is often secondary generalization. Some patients show abnormal interictal EEG, and some patients may have intellectual disability or autism spectrum disorders. Seizure onset usually occurs in the first or second decades, although later onset has been reported, and there is phenotypic variability within families. Penetrance of the disorder is incomplete.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
16.3 TPM
Testículo
13.5 TPM
Linfócitos
10.8 TPM
Baço
10.6 TPM
Cervix Ectocervix
10.5 TPM
OUTRAS DOENÇAS (5)
epilepsy, familial focal, with variable foci 1developmental and epileptic encephalopathy 111familial focal epilepsy with variable fociundetermined early-onset epileptic encephalopathy
HGNC:18423UniProt:O75140
PARS2Probable proline--tRNA ligase, mitochondrialDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Mitochondrial tRNA aminoacylation
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 75

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE75 is an autosomal recessive form characterized by onset of severe refractory seizures in the first months of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
12.0 TPM
Linfócitos
8.8 TPM
Fibroblastos
6.5 TPM
Útero
6.2 TPM
Cervix Endocervix
5.6 TPM
OUTRAS DOENÇAS (2)
developmental and epileptic encephalopathy, 75undetermined early-onset epileptic encephalopathy
HGNC:30563UniProt:Q7L3T8
CACNA2D1Voltage-dependent calcium channel subunit alpha-2/delta-1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Presynaptic depolarization and calcium channel opening
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 110

A form of epileptic encephalopathy, a heterogeneous group of early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE110 is an autosomal recessive form characterized by profound global developmental delay and hypotonia apparent in infancy followed by onset of seizures in the first months or years of life.

OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy 110undetermined early-onset epileptic encephalopathyBrugada syndromeshort QT syndrome
HGNC:1399UniProt:P54289
CLTCClathrin heavy chain 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
Gap junction degradationFormation of annular gap junctionsEPH-ephrin mediated repulsion of cellsEntry of Influenza Virion into Host Cell via EndocytosisRetrograde neurotrophin signalling
MECANISMO DE DOENÇA

Intellectual developmental disorder, autosomal dominant 56

A form of intellectual disability, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period.

OUTRAS DOENÇAS (5)
intellectual disability, autosomal dominant 56inflammatory myofibroblastic tumorMIT family translocation renal cell carcinomaundetermined early-onset epileptic encephalopathy
HGNC:2092UniProt:Q00610

Variantes genéticas (ClinVar)

405 variantes patogênicas registradas no ClinVar.

🧬 TRAK1: GRCh37/hg19 3p26.3-14.3(chr3:2263690-55016039)x3 ()
🧬 TRAK1: NM_001042646.3(TRAK1):c.1963+12C>G ()
🧬 TRAK1: NM_001042646.3(TRAK1):c.1744+1353G>T ()
🧬 TRAK1: NM_001042646.3(TRAK1):c.286+2T>G ()
🧬 TRAK1: NM_001042646.3(TRAK1):c.1879G>A (p.Asp627Asn) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

143 vias biológicas associadas aos genes desta condição.

Signaling by BRAF and RAF1 fusions RHOT2 GTPase cycle RHOT1 GTPase cycle Nuclear signaling by ERBB4 Negative regulation of activity of TFAP2 (AP-2) family transcription factors Activation of the TFAP2 (AP-2) family of transcription factors Signaling by ERBB4 GABA receptor activation Regulation of MECP2 expression and activity FOXO-mediated transcription of cell cycle genes Voltage gated Potassium channels Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Synthesis of dolichyl-phosphate Defective DHDDS causes RP59 Interaction between L1 and Ankyrins Phase 0 - rapid depolarisation Amino acid transport across the plasma membrane Regulation of actin dynamics for phagocytic cup formation VEGFA-VEGFR2 Pathway RHO GTPases Activate WASPs and WAVEs RAC1 GTPase cycle FCGR3A-mediated phagocytosis Ion homeostasis Ion transport by P-type ATPases Potential therapeutics for SARS SLC-mediated transport of organic anions RMTs methylate histone arginines RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) ROS and RNS production in phagocytes Insulin receptor recycling Transferrin endocytosis and recycling Amino acids regulate mTORC1 Ion channel transport Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy MAP2K and MAPK activation Signaling by moderate kinase activity BRAF mutants Signaling by high-kinase activity BRAF mutants Paradoxical activation of RAF signaling by kinase inactive BRAF Signaling downstream of RAS mutants Signaling by RAF1 mutants Synthesis of PIPs at the plasma membrane Synthesis of IP2, IP, and Ins in the cytosol Synthesis of IP3 and IP4 in the cytosol Clathrin-mediated endocytosis Antigen processing: Ubiquitination & Proteasome degradation Dengue Virus Attachment and Entry Sensory perception of sweet, bitter, and umami (glutamate) taste Golgi Associated Vesicle Biogenesis Cargo recognition for clathrin-mediated endocytosis Unblocking of NMDA receptors, glutamate binding and activation Ras activation upon Ca2+ influx through NMDA receptor RAF/MAP kinase cascade Neurexins and neuroligins Synaptic adhesion-like molecules Assembly and cell surface presentation of NMDA receptors Negative regulation of NMDA receptor-mediated neuronal transmission Long-term potentiation PIP3 activates AKT signaling NGF-independant TRKA activation Constitutive Signaling by Aberrant PI3K in Cancer PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling BDNF activates NTRK2 (TRKB) signaling NTF3 activates NTRK2 (TRKB) signaling NTF4 activates NTRK2 (TRKB) signaling Activated NTRK2 signals through RAS Activated NTRK2 signals through PLCG1 Activated NTRK2 signals through PI3K Activated NTRK2 signals through FRS2 and FRS3 Activated NTRK2 signals through FYN NTRK2 activates RAC1 Activated NTRK2 signals through CDK5 Autodegradation of Cdh1 by Cdh1:APC/C SCF-beta-TrCP mediated degradation of Emi1 APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase Regulation of APC/C activators between G1/S and early anaphase Phosphorylation of Emi1 Senescence-Associated Secretory Phenotype (SASP) Assembly of the pre-replicative complex CDK-mediated phosphorylation and removal of Cdc6 Cyclin A/B1/B2 associated events during G2/M transition Cyclin A:Cdk2-associated events at S phase entry Transcriptional Regulation by VENTX Aberrant regulation of mitotic exit in cancer due to RB1 defects HCN channels Activation of G protein gated Potassium channels G alpha (i) signalling events Class C/3 (Metabotropic glutamate/pheromone receptors) GABA B receptor activation Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits Astrocytic Glutamate-Glutamine Uptake And Metabolism Glutamate Neurotransmitter Release Cycle SLC-mediated transport of amino acids Toll Like Receptor 4 (TLR4) Cascade Retrograde neurotrophin signalling Gap junction degradation Formation of annular gap junctions MHC class II antigen presentation EPH-ephrin mediated repulsion of cells Recycling pathway of L1 DARPP-32 events Calcineurin activates NFAT FCERI mediated Ca+2 mobilization Ca2+ pathway CLEC7A (Dectin-1) induces NFAT activation Cytosolic tRNA aminoacylation Activation of BAD and translocation to mitochondria Translocation of SLC2A4 (GLUT4) to the plasma membrane Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Anchoring of the basal body to the plasma membrane RHO GTPases activate PKNs TP53 Regulates Metabolic Genes Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex AURKA Activation by TPX2 Regulation of localization of FOXO transcription factors SARS-CoV-1 targets host intracellular signalling and regulatory pathways SARS-CoV-2 targets host intracellular signalling and regulatory pathways Transcriptional and post-translational regulation of MITF-M expression and activity SPOP-mediated proteasomal degradation of PD-L1(CD274) Presynaptic depolarization and calcium channel opening Regulation of insulin secretion Eukaryotic Translation Elongation PPARA activates gene expression Transcriptional regulation of white adipocyte differentiation RSV-host interactions Regulation of RAS by GAPs Mitochondrial tRNA aminoacylation Mechanical load activates signaling by PIEZO1 and integrins in osteocytes Entry of Influenza Virion into Host Cell via Endocytosis Lysosome Vesicle Biogenesis WNT5A-dependent internalization of FZD4 WNT5A-dependent internalization of FZD2, FZD5 and ROR2 VLDLR internalisation and degradation LDL clearance RHOU GTPase cycle RHOV GTPase cycle ALK mutants bind TKIs Signaling by ALK fusions and activated point mutants

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Encefalopatia epiléptica de início precoce inespecífica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Variants loci and phenotype correlation of TRIM8-related neuro-renal syndrome: three cases reports and literature review.

Frontiers in neurology2024

TRIM8-related neuro-renal syndrome (NRS), caused by pathogenic variants of the TRIM8 gene, is characterized by epilepsy, developmental delay (DD) and renal disorders. The severity of the neurological effects as well as the presence of renal disorders is variable among patients. Here, we report three additional patients with clinical features compatible with NRS and summarize the association between the variants' loci and phenotype of TIRM8-related NRS. A retrospective analysis was conducted for three Chinese children with NRS due to TRIM8 variants identified through whole-exome sequencing (WES). Previous reports of patients with TRIM8-related NRS were reviewed systematically. Demographic and clinical data were collected from these patients. Two de novo TRIM8 truncating variants in three NRS patients were identified in our study, including c.1327_c.1328delCCinsTG (p. Arg443*) and c.1375C>T (p.Gln459*). Our three patients all exhibited drug-resistant epilepsy and early-onset DD, and two of whom developed electrical status epilepticus during sleep (ESES). Brain magnetic resonance imaging (MRI) showed periventricular leukomalacia in one patient and normal in the other two. All three patients demonstrated nephrotic range proteinuria (NRP) or nephrotic syndrome (NS) with normal renal function during follow-up. There was a total of 27 patients with TRIM8-related NRS have been identified to date. The most common clinical features are renal diseases (89%), DD (89%), followed by epilepsy (78%). 67% of patients eventually progressed to end-stage renal disease (ESRD). Focal seizure was the most frequent seizure type (57%). 52% of patients presented drug-resistant epilepsy. 64% of patients exhibited non-specific brain MRI abnormalities. Brain atrophy was the most common change (50%). Two patients with TRIM8 variants closer to the N-terminal had neurological diseases without renal damage. Five patients with TRIM8 variants closer to the C-terminal had no severe neurological diseases. Seven patients had Gln459* variant which is the most common variant (7/27, 25.9%). The severity of the renal and neurological damage of the seven patients was variable. This study expands the number of individuals with confirmed NRS due to pathogenic variants in TRIM8. Neurological and renal phenotype with the same variant locus differed in their severity. Further research is needed to explore the relationship between genotype and phenotype of TRIM8 variants.

#2

Clinical and molecular heterogeneity in CDLK5 disorders.

Boletin medico del Hospital Infantil de Mexico2023

CDKL5 deficiency syndrome is caused by pathogenic variants in the CDKL5 gene, with a variable clinical spectrum ranging from patients with characteristics of autism spectrum disorder to early-onset epilepsy refractory to treatment. Initially, until the gene was discovered, it was considered an atypical form of Rett syndrome. This study aimed to describe the clinical and molecular heterogeneity in CDLK5 disorders among three female patients with CDKL5 pathogenic variants. We reported three unrelated Mexican female patients evaluated for global developmental delay and epilepsy. All three cases were hemizygotes to a CDKL5 pathogenic variant. In one patient, we performed a 306 gene panel associated with epilepsy. In the other two cases, a human genomic microarray was performed. We describe their clinical features electroencephalogram and brain magnetic resonance evaluations. CDKL5 deficiency syndrome represents a challenge for clinicians since the clinical manifestations, electroencephalographic and neuroimaging studies can be non-specific. This syndrome should be suspected in the presence of global developmental delay, autistic behavioral phenotype and epilepsy, associated or not with dysmorphia. Given the similarity between various epileptic encephalopathies, multigene panels including sequencing and duplication/deletion analysis should be requested in which this gene and its possible differential diagnoses are considered, without forgetting the usefulness of genomic techniques in unclear cases. El síndrome por deficiencia de CDKL5 es originado por variantes patogénicas en el gen CDKL5, con un espectro clínico variable que va desde pacientes con características del trastorno del espectro autista hasta epilepsia de inicio temprano y refractaria al tratamiento. Inicialmente fue considerado como una forma atípica de síndrome de Rett. Presentamos tres pacientes no relacionadas, evaluadas por retraso global del desarrollo y epilepsia refractaria. Los tres casos eran hemicigotos a una variante patógena de CDKL5. En una paciente se realizó panel de 306 genes asociados con epilepsia; en las otras dos se realizó microarreglo genómico comparativo. Las características clínicas y los hallazgos en el electroencefalograma y la resonancia magnética cerebral se han descrito clásicamente en el espectro de manifestaciones de este síndrome. El síndrome por deficiencia de CDKL5 representa un reto para los médicos, ya que en muchos casos las manifestaciones clínicas y los estudios electroencefalográficos y de neuroimagen pueden ser inespecíficos. Debe sospecharse este síndrome ante la presencia de retraso global del desarrollo, fenotipo conductual autista y epilepsia, asociado o no con dismorfias. Dada la similitud entre diversas encefalopatías epilépticas, se deben solicitar paneles multigénicos que incluyan la secuenciación y el análisis de duplicación/deleción en los que se contemple este gen y sus posibles diagnósticos diferenciales, aunque sin olvidar la utilidad de las técnicas genómicas en casos poco claros.

#3

A Novel Variant of the CHD2 Gene Associated With Developmental Delay and Myoclonic Epilepsy.

Frontiers in genetics2022

Pathogenic variants in CHD2 have been reported to have a wide range of phenotypic variability in neurodevelopmental disorders, such as early-onset epileptic encephalopathy, developmental delay, and behavior problems. So far, there is no clear correlation between genotypes and phenotypes. This study reports a Chinese patient with a novel heterozygous CHD2 mutation (c.4318C>T, pArg1440*). Her main clinical manifestations include developmental delay, myoclonic epilepsy, and hypothyroidism. Then, we reviewed a total of 144 individuals carrying CHD2 variants with epileptic encephalopathy. In terms of clinical manifestations, these patients are usually described with variable epilepsy phenotypes, including idiopathic photosensitive occipital epilepsy, Dravet syndrome, Jeavons syndrome, Lennox-Gastaut syndrome, juvenile myoclonic epilepsy, and non-specific epileptic encephalopathy. Among them, myoclonic seizures and generalized tonic-clonic seizures are the main seizure types in all patients hosting CHD2 single-nucleotide or indel variants (non-CNVs). At the molecular level, there are 102 types of CHD2 non-CNVs in 126 patients, almost one mutational type corresponding to one person, and there is no difference in the incidence ratio of each position. Furthermore, we summarized that a small proportion of patients inherited CHD2 variants, and not all patients with CHD2 variants had seizures. Importantly, the phenotypes, especially seizures control and fever sensitivity, and genotypes had a relative association. These results enriched the database of CHD2-relative neurodevelopmental disorders and provided a theoretical foundation for researching the relationship between genotypes and phenotypes.

#4

Human COQ4 deficiency: delineating the clinical, metabolic and neuroimaging phenotypes.

Journal of medical genetics2022 Sep

Human coenzyme Q4 (COQ4) is essential for coenzyme Q10 (CoQ10) biosynthesis. Pathogenic variants in COQ4 cause childhood-onset neurodegeneration. We aimed to delineate the clinical spectrum and the cellular consequences of COQ4 deficiency. Clinical course and neuroradiological findings in a large cohort of paediatric patients with COQ4 deficiency were analysed. Functional studies in patient-derived cell lines were performed. We characterised 44 individuals from 36 families with COQ4 deficiency (16 newly described). A total of 23 different variants were identified, including four novel variants in COQ4. Correlation analyses of clinical and neuroimaging findings revealed three disease patterns: type 1: early-onset phenotype with neonatal brain anomalies and epileptic encephalopathy; type 2: intermediate phenotype with distinct stroke-like lesions; and type 3: moderate phenotype with non-specific brain pathology and a stable disease course. The functional relevance of COQ4 variants was supported by in vitro studies using patient-derived fibroblast lines. Experiments revealed significantly decreased COQ4 protein levels, reduced levels of cellular CoQ10 and elevated levels of the metabolic intermediate 6-demethoxyubiquinone. Our study describes the heterogeneous clinical presentation of COQ4 deficiency and identifies phenotypic subtypes. Cell-based studies support the pathogenic characteristics of COQ4 variants. Due to the insufficient clinical response to oral CoQ10 supplementation, alternative treatment strategies are warranted.

#5

Phenotypic spectrum of patients with GABRB2 variants: from mild febrile seizures to severe epileptic encephalopathy.

Developmental medicine and child neurology2020 Oct

To characterize the different phenotypes of GABRB2-related epilepsy and to establish a genotype-phenotype correlation. We used next-generation sequencing to identify GABRB2 variants in 15 patients. Eleven GABRB2 variants were novel and 12 were de novo. The age at the onset of seizures ranged from 1 day to 26 months. Nine patients had multiple seizure types, including focal seizures, generalized tonic-clonic seizures, myoclonic seizures, epileptic spasms, and atonic seizures. Seizures were fever-sensitive in 13 out of the 15 patients. Eleven patients displayed developmental delay, while 11 had abnormal video electroencephalography. Abnormalities in the brain images included dysplasia of the frontal and temporal cortex, dysplasia of the corpus callosum, and delayed myelination in four patients. One patient was diagnosed with febrile seizures, three with febrile seizures plus, three with Dravet syndrome, three with West syndrome, one with Ohtahara syndrome, three with developmental delays and epilepsy, and one with non-specific early-onset epileptic encephalopathy. The most common phenotypes of patients with GABRB2 variants include early onset of seizure and fever sensitivity. Febrile seizures and febrile seizures plus are new phenotypes of GABRB2 variants. The phenotypic spectrum of GABRB2 variants ranges from mild febrile seizures to severe epileptic encephalopathy. 目的: 总结GABRB2基因相关癫痫的不同表型特点及基因型-表型相关性研究 方法: 采用二代测序技术的方法发现15例患者携带GABRB2基因变异 结果: 15例GABRB2基因变异中11例为新发现的变异,12例为新生变异。癫痫起病年龄范围从生后第1天至26月龄。共有9名患者有多种癫痫发作形式,包括局灶性发作,全面性强直阵挛发作,肌阵挛发作,癫痫性痉挛发作和失张力发作。15例患者中有13例出现癫痫热敏感。11例患者出现发育落后,且有脑电图异常。4例患者出现头颅影像异常,包括额颞区皮质发育不良,胼胝体发育不良,髓鞘化延迟。癫痫诊断包括热性惊厥1例,热性惊厥附加症3例,Dravet综合征3例,婴儿痉挛症3例,大田原综合征1例,发育落后与癫痫3例,不能分类的早发癫痫性脑病1例。 结论: GABRB2基因变异导致的最常见表型包括癫痫起病年龄早和癫痫热敏感。热性惊厥和热性惊厥附加症是GABRB2基因变异的新表型。GABRB2基因变异的表型谱广泛,从表型轻的热性惊厥到严重的癫痫性脑病。.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Encefalopatia epiléptica de início precoce inespecífica.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Encefalopatia epiléptica de início precoce inespecífica e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

A condição é associada a alterações em diferentes genes, como TRAK1, WWOX, SCN8A e SLC13A5. Essas alterações genéticas podem seguir padrões de herança autossômica dominante, autossômica recessiva ou ligada ao cromossomo X.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

7 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. Clinical and molecular heterogeneity in CDLK5 disorders.
    Boletin medico del Hospital Infantil de Mexico2023PMID 37490689
  2. ORPHA:442835
    Orphanet
  3. GARD:15028
    GARD (NIH)
  4. Q56014174
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Encefalopatia epiléptica de início precoce inespecífica. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/encefalopatia-epileptica-de-inicio-precoce-inespecifica

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Encefalopatia epiléptica de início precoce inespecífica

ORPHA:442835 · MONDO:0018614
🇧🇷 Brasil SUS
SIGTAP
2 procedimentos
Geral
Prevalência
Unknown
Herança
Autosomal dominant, Autosomal recessive, Not applicable, X-linked recessive
CID-10
G40.4 · Outras epilepsias e síndromes epilépticas generalizadas
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C5680057
Wikidata

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Rara